Insufficient protein accelerates muscle breakdown, and since muscle tissue drives metabolic rate, losing muscle makes fatigue worse
Exenatide, a GLP-1 receptor agonist, has a half-life of about 2.4 hours
The first was a multi-center study that used data from 33,021 participants and found that GLP-1/GIP agonist and SGLT2 inhibitor use were associated with comparable rates of new retinopathy development and worsening of existing nonproliferative retinopathy
1105 However, the specific protective mechanisms of these drugs still require further investigation, including their impact on mitochondrial complexes, modulation of the calcium ion balance, and stabilization of mtDNA
The choice of formulation depends on the specific medication, the indication (diabetes or weight management), patient preference, and clinical suitability
This method allows for steady absorption into the bloodstream